Aventis Limits Tripedia Orders, Focusing On Td Vaccine Production
Executive Summary
Aventis Pasteur is limiting orders for the DTaP vaccine Tripedia while it concentrates on increasing supplies of adult tetanus booster vaccine.
You may also be interested in...
FDA Vaccine Regulation To Be Scrutinized By Senate Health Committee
The Senate Health Committee will push for changes in FDA's approach to vaccine regulation, committee health counsel Steve Irizarre told the Banc of America healthcare forum Dec. 10 in New York
FDA Vaccine Regulation To Be Scrutinized By Senate Health Committee
The Senate Health Committee will push for changes in FDA's approach to vaccine regulation, committee health counsel Steve Irizarre told the Banc of America healthcare forum Dec. 10 in New York
Aventis Daptacel May Alleviate DTaP Shortage; Approval Expected Shortly
Aventis Pasteur expects the approval of Daptacel to enable the company to resume filling CDC contracts for diphtheria, tetanus and acellular pertussis vaccine